Testing a new targeted therapy for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called HRS-6208 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and if it can help shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor cancer that has spread or cannot be removed, and standard treatments have stopped working or are not an option.
- You are between 18 and 75 years old.
- You have at least one tumor that can be measured on a scan.
- You are able to take care of yourself and are up and about more than half the day (ECOG score 0-1).
- You have not had another cancer in the last 5 years (except for cured skin or early cervical cancer).
- Side effects from any past cancer treatments have mostly resolved.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HRS-7058 combined with other anti-tumor medicines for people with solid tumors. The goal is to see if the combination is safe and effective. It might be an option if you have advanced cancer and have not responded to other treatments.
This trial tests two drugs, HRS-4642 and SHR-A2102, for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if this combination can help shrink or slow tumor growth.
This study tests a new drug called SHR-8203 for people with advanced solid tumors that have stopped responding to standard treatments or have no treatment options. The goal is to see if the drug is safe and helps shrink or control the tumor.
This trial tests a new drug called HRS-6768 for people with advanced solid tumors that have stopped responding to standard treatments or have no good options. It aims to see if the drug is safe and effective.
This trial tests a new drug called HRS-4508 for people with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe, how the body processes it, and if it helps shrink tumors.
This trial tests an experimental drug called HRS-3802 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and how the body processes it.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.